Audrey Jacqulynn Zeh, NP
Nurse Practitioner · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Audrey Jacqulynn Zeh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$3,170
Medicare paid this office $3,170 for 22 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 17 | $2,469 | $130 |
Who their Medicare patients are
22 Original Medicare patients in 2024. Average age 69 · Health risk score 3.07. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 68%.
The office billed $13,689, Medicare allowed $3,979 and paid $3,170; for 26 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 22 | 26 | 69 | 3.07 | $13,689 | $3,170 |
| 2023 | 37 | 67 | 70 | 3.03 | $27,306 | $5,211 |
| 2022 | 63 | 176 | 72 | 2.39 | $57,336 | $12,338 |
| 2021 | 14 | 21 | 71 | 2.44 | $6,947 | $1,652 |
| 2016 | 84 | 180 | 74 | 1.38 | $14,623 | $7,420 |
| 2015 | 130 | 268 | 73 | 1.42 | $22,444 | $11,473 |
| 2014 | 46 | 80 | 73 | 1.04 | $6,526 | $3,412 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Long return visit (40+ min) | 21 | $3,051 | $92 |
2022: 3 services
| Return visit (30+ min) | 32 | $7,557 | $70 |
| Long return visit (40+ min) | 22 | $2,990 | $88 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $284 | $26 |
2016: 3 services
| Return visit (30+ min) | 22 | $1,896 | $73 |
| Short return visit (20+ min) | 36 | $1,771 | $44 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,288 | $107 |
2015: 4 services
| Return visit (30+ min) | 46 | $3,706 | $69 |
| Short return visit (20+ min) | 58 | $2,900 | $43 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $1,837 | $108 |
| Short return visit | 11 | $211 | $19 |
2014: 2 services
| Short return visit (20+ min) | 23 | $1,283 | $53 |
| Return visit (30+ min) | 13 | $1,022 | $79 |
Drugs they prescribed that Part D paid
$115,171
Pharmacies billed $115,171 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 57) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
0 generic and 47 brand-name prescriptions · $115,171 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 29 | $18,246 | $629 |
Year by year
| 2024 | 57 | 17 | 0% (0) | 82% | $115,171 |
| 2023 | 76 | 26 | None | None | $4,508 |
| 2022 | 211 | 45 | 11% (23) | None | $327,810 |
| 2021 | 278 | 73 | 11% (31) | None | $1,285,516 |
| 2020 | 331 | 69 | 14% (45) | None | $822,965 |
| 2019 | 304 | 74 | 11% (34) | 22% | $220,745 |
| 2018 | 277 | 61 | 11% (30) | 24% | $221,968 |
| 2017 | 171 | 46 | 8% (14) | None | $34,963 |
| 2016 | 475 | 105 | None | None | $17,966 |
| 2015 | 410 | 126 | 3% (11) | None | $28,224 |
| 2014 | 70 | 41 | None | 19% | $2,267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Levothyroxine | 24 | $509 | $21 |
2022: 4 drugs
| Gabapentin | 16 | $904 | $57 |
| Levothyroxine | 42 | $776 | $18 |
| Oxycodone | 16 | $529 | $33 |
| Dexamethasone | 13 | $370 | $28 |
2021: 6 drugs
| Imbruvica | 15 | $572,162 | $38,144 |
| Tagrisso | 18 | $281,054 | $15,614 |
| Eliquis | 35 | $20,669 | $591 |
| Levothyroxine | 18 | $304 | $17 |
| Anastrozole | 15 | $287 | $19 |
| Gabapentin | 11 | $212 | $19 |
2020: 7 drugs
| Tagrisso | 23 | $367,218 | $15,966 |
| Mekinist | 11 | $136,164 | $12,379 |
| Eliquis | 14 | $9,799 | $700 |
| Oxycodone | 14 | $993 | $71 |
| Ondansetron | 12 | $516 | $43 |
| Levothyroxine | 24 | $308 | $13 |
| Anastrozole | 11 | $199 | $18 |
2019: 4 drugs
| Ondansetron Odt | 11 | $374 | $34 |
| Prochlorperazine Maleate | 16 | $205 | $13 |
| Levothyroxine | 11 | $171 | $16 |
| Lorazepam | 19 | $134 | $7 |
2018: 7 drugs
| Oxycodone | 16 | $891 | $56 |
| Diphenoxylate-Atropine | 12 | $885 | $74 |
| Ondansetron Odt | 19 | $651 | $34 |
| Hydrocortisone | 15 | $554 | $37 |
| Levothyroxine | 15 | $134 | $9 |
| Prochlorperazine Maleate | 16 | $106 | $7 |
| Lorazepam | 15 | $56 | $4 |
2017: 3 drugs
| Metoprolol | 11 | $104 | $9 |
| Amlodipine Besylate | 15 | $97 | $6 |
| Lorazepam | 12 | $66 | $6 |
2016: 17 drugs
| Promethegan | 11 | $1,254 | $114 |
| Fluoxetine | 15 | $610 | $41 |
| Oxybutynin Chloride | 11 | $364 | $33 |
| Ibuprofen | 12 | $287 | $24 |
| Levothyroxine | 19 | $267 | $14 |
| Ondansetron | 12 | $199 | $17 |
| Omeprazole | 11 | $180 | $16 |
| Azithromycin | 11 | $151 | $14 |
| Lisinopril | 16 | $145 | $9 |
| Warfarin | 16 | $144 | $9 |
| Ciprofloxacin | 11 | $138 | $13 |
| Metoprolol | 13 | $136 | $10 |
| Gabapentin | 21 | $133 | $6 |
| Amlodipine Besylate | 23 | $123 | $5 |
| Atenolol | 14 | $86 | $6 |
| Losartan | 14 | $54 | $4 |
| Metformin | 20 | $45 | $2 |
2015: 5 drugs
| Montelukast | 12 | $120 | $10 |
| Losartan | 21 | $110 | $5 |
| Fluoxetine | 12 | $109 | $9 |
| Azithromycin | 14 | $97 | $7 |
| Fluconazole | 11 | $60 | $5 |
Money from drug and device companies
$344 in 2025
| 2025 | 3 | 8 | None | $344 |
| 2024 | 1 | 1 | None | $185 |
| 2023 | 1 | 1 | None | $119 |
| 2022 | 1 | 1 | None | $125 |
| 2021 | 1 | 1 | None | $69 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Enhertu | $154 | 3 payments
|
| Pharmacosmos Therapeutics | Monoferric | $122 | 1 payment
|
| Daiichi Sankyo | Datroway | $69 | 3 payments
|
See all 7 published payments
| Daiichi Sankyo | Meals · 2025-11-21 | Datroway | $22 |
| Daiichi Sankyo | Meals · 2025-08-18 | Datroway | $25 |
| Daiichi Sankyo | Meals · 2025-06-27 | Enhertu | $21 |
| Pharmacosmos Therapeutics | Meals · 2025-05-21 | Monoferric | $122 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-14 | Imfinzi | $5 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-14 | Enhertu | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Enhertu | $123 |
See earlier years (2024, 2023, 2022, 2021)
2024: $185
| Genzyme | Altuviiio | $185 | 1 payment
|
2023: $119
| Foundation Medicine | None | $119 | 1 payment
|
2022: $125
| AstraZeneca Pharmaceuticals LP | Calquence | $125 | 1 payment
|
2021: $69
| Seagen | Tukysa | $69 | 1 payment
|
Professional record
- NPI
- 1689090078
- Licence
- CA 95000505
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-03-11
- NPI last updated
- 2025-04-29
- NPI record certified
- 2025-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: UCLA Health 100 Medical Plaza Suite 550/555, Los Angeles, CA, 90095 · 200 W Arbor Dr, San Diego, CA, 92103